One NSCLC with an NPTN-RASGRF1 fusion also harbored both a classic activating EGFR Exon 19 deletion and an ADPGK-NTRK3 fusion, both established oncogenic drivers in NSCLC (Supplementary Fig. 2). This evidence concerns the gene EGFR and non-small cell lung carcinoma.